Hitoshi Ogashiwa

Influence of easing COVID-19 strategies following downgrading of the national infectious disease category on COVID-19 occurrence among hospitalized patients in Japan.

K. Nakajima, T. Ueda, Mika Morosawa, 2024, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Judicious ending of isolation based on reverse transcription–polymerase chain reaction (RT-PCR) cycle threshold only for patients with coronavirus disease 2019 (COVID-19) requiring in-hospital therapy for longer than 20 days after symptom onset

K. Nakajima, Y. Takesue, T. Ueda, 2023, Journal of Infection and Chemotherapy.